Globally, Asia Pacific accounts for the largest market share of Vitamin B9 (Folic Acid) Market and is estimated to lead
the overall market in the years to come. Medical and therapeutic sectors are the major consumer of Vitamin B9 (Folic
Acid) in this region. The reason being, rising investment in product innovation, growing manufacturing base, use of
advanced technologies and expertise, and Research and development sectors. China is a key producer of Folic Acid.
This is mainly due to the execution of the Environmental Protection Law.
The key players of Vitamin B9 (Folic Acid) Market are Jiheng Pharmaceutical, DSM, Niutang, BASF, Bio-Rad
Laboratories, Hoffmann-La Roche, Novartis, Becton, BioMerieux, Dickinson and Company, Siemens Healthineers,
Beckman Coulter, Abbott Laboratories, and Xinfa Pharmaceutical. These players are concentrating on inorganic growth
to sustain themselves amongst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of
the hour.
Get a Sample Copy of This Report @
https://www.millioninsights.com/industry-reports/vitamin-b9-folic-acid-market/request-sample
Market Segment:
This report studies Vitamin B9 (Folic Acid) in Global market, especially in North America, Europe, China, Japan,
Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and
market share for each manufacturer, covering
• DSM
• BASF
• Xinfa Pharmaceutical
• Niutang
• Jiheng Pharmaceutical
Market Segment by Regions, this report splits Global into several key Region, with production, consumption,
revenue, market share and growth rate of Vitamin B9 (Folic Acid) in these regions, from 2011 to 2021 (forecast), like
• North America
• China
• Europe